Aflibercept for diabetic macular edema

被引：0

作者：

Udaondo, Patricia ^{[1
]}

Garcia-Delpech, Salvador ^{[1
]}

Matinez-Costa, Rafael ^{[1
]}

Navarro-Piera, Juan ^{[2
]}

Cisneros-Lanuza, Angel ^{[1
]}

机构：

[1] La Fe Univ & Polytech Hosp, Valencia, Spain

[2] Francesc Borja Hosp, Gandia, Spain

来源：

EXPERT REVIEW OF OPHTHALMOLOGY | 2014年 / 9卷 / 04期

关键词：

aflibercept; anti-VEGF; avastin; intravitreal injection; laser; macula; macular degeneration; macular edema; anibizumab; retina;

D O I：

10.1586/17469899.2014.931809

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Different intravitreal anti-VEGF medications have been used for the management of retinal vascular disorders with highly satisfactory results and good safety profiles. Aflibercept, a new anti-VEGF drug with a different mechanism of action compared with prior therapies, has recently emerged. The results of aflibercept Phase II and III studies show its efficacy for the treatment of wet age-related macular degeneration, macular edema secondary to central retinal vein occlusion and diabetic macular edema.

引用

页码：263 / 268

页数：6

共 50 条

[11] Aflibercept monotherapy or bevacizumab first for diabetic macular edema
Hostovsky, Avner
Moroz, Iris
Katz, Gabriel
INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 2) : S260 - S264
[12] Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
Klein K.A.
Cleary T.S.
Reichel E.
International Journal of Retina and Vitreous, 3 (1)
[13] Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Jhaveri, Chirag D.
Glassman, Adam R.
Ferris, Frederick L., III
Liu, Danni
Maguire, Maureen G.
Allen, John B.
Baker, Carl W.
Browning, David
Cunningham, Matthew A.
Friedman, Scott M.
Jampol, Lee M.
Marcus, Dennis M.
Martin, Daniel F.
Preston, Carin M.
Stockdale, Cynthia R.
Sun, Jennifer K.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (08): : 692 - 703
[14] Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
Maris, Dimitrios
Dastiridou, Anna
Kotoula, Maria
Karathanou, Aikaterini
Tsironi, Evangelia E.
Bargiota, Alexandra
Androudi, Sofia
DIAGNOSTICS, 2024, 14 (12)
[15] Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
Ohara, Hiromi
Harada, Yosuke
Hiyama, Tomona
Sadahide, Ayako
Minamoto, Akira
Kiuchi, Yoshiaki
MEDICINA-LITHUANIA, 2023, 59 (06):
[16] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
Lim, Laurence S.
Ng, Wei Yan
Mathur, Ranjana
Wong, Doric
Wong, Edmund Y. M.
Yeo, Ian
Cheung, Chui Ming Gemmy
Lee, Shu Yen
Wong, Tien Yin
Papakostas, Thanos D.
Kim, Leo A.
CLINICAL OPHTHALMOLOGY, 2015, 9 : 1715 - 1718
[17] Efficacy of intravitreal aflibercept injection in eyes with diabetic macular edema
Shimizu, Norihiro
Oshitari, Toshiyuki
Tatsumi, Tomoaki
Sato, Eiju
Takatsuna, Yoko
Yamamoto, Shuichi
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[18] THE EFFECT OF AGE ON AFLIBERCEPT (EYLEA) RESPONSE IN DIABETIC MACULAR EDEMA
Ozsaygili, Cemal
Duru, Zeynep
Cicek, Ayse
Ulusoy, Dondu Melek
Demirtas, Atilim Armagan
Duru, Necati
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (06): : 1038 - 1043
[19] Intravitreal aflibercept for diabetic macular edema: structural and functional improvements
Zhang, Chuanhe
Chen, Tianyu
Jia, Ru
Gong, Di
Liu, Zhigao
Wu, Changlong
Shu, Xiangwen
Han, Fangju
Gong, Bin
FRONTIERS IN MEDICINE, 2025, 12
[20] Aflibercept in the treatment of diabetic macular edema: a review and consensus paper
Avitabile, Teresio
Azzolini, Claudio
Bandello, Francesco
Boscia, Francesco
De Falco, Sandro
Fornasari, Diego
Lanzetta, Paolo
Mastropasqua, Leonardo
Midena, Edoardo
Ricci, Federico
Staurenghi, Giovanni
Varano, Monica
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (06) : 627 - 639

← 1 2 3 4 5 →